See HB - Search Results

1

NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing.

White CW, Johnstone EKM, See HB, Pfleger KDG. White CW, et al. Among authors: see hb. Cell Signal. 2019 Feb;54:27-34. doi: 10.1016/j.cellsig.2018.11.018. Epub 2018 Nov 22. Cell Signal. 2019. PMID: 30471466 Free article.

2

Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time.

White CW, Vanyai HK, See HB, Johnstone EKM, Pfleger KDG. White CW, et al. Among authors: see hb. Sci Rep. 2017 Jun 9;7(1):3187. doi: 10.1038/s41598-017-03486-2. Sci Rep. 2017. PMID: 28600500 Free PMC article.

3

Investigation of Receptor Heteromers Using NanoBRET Ligand Binding.

Johnstone EKM, See HB, Abhayawardana RS, Song A, Rosengren KJ, Hill SJ, Pfleger KDG. Johnstone EKM, et al. Among authors: see hb. Int J Mol Sci. 2021 Jan 22;22(3):1082. doi: 10.3390/ijms22031082. Int J Mol Sci. 2021. PMID: 33499147 Free PMC article.

4

Demonstration of improvements to the bioluminescence resonance energy transfer (BRET) technology for the monitoring of G protein-coupled receptors in live cells.

Kocan M, See HB, Seeber RM, Eidne KA, Pfleger KD. Kocan M, et al. Among authors: see hb. J Biomol Screen. 2008 Oct;13(9):888-98. doi: 10.1177/1087057108324032. Epub 2008 Sep 23. J Biomol Screen. 2008. PMID: 18812574

5

Application of G protein-coupled receptor-heteromer identification technology to monitor β-arrestin recruitment to G protein-coupled receptor heteromers.

See HB, Seeber RM, Kocan M, Eidne KA, Pfleger KD. See HB, et al. Assay Drug Dev Technol. 2011 Feb;9(1):21-30. doi: 10.1089/adt.2010.0336. Epub 2010 Dec 6. Assay Drug Dev Technol. 2011. PMID: 21133678 Free PMC article.

6

Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer.

Mustafa S, See HB, Seeber RM, Armstrong SP, White CW, Ventura S, Ayoub MA, Pfleger KD. Mustafa S, et al. Among authors: see hb. J Biol Chem. 2012 Apr 13;287(16):12952-65. doi: 10.1074/jbc.M111.322834. Epub 2012 Feb 27. J Biol Chem. 2012. PMID: 22371491 Free PMC article.

7

Profiling epidermal growth factor receptor and heregulin receptor 3 heteromerization using receptor tyrosine kinase heteromer investigation technology.

Ayoub MA, See HB, Seeber RM, Armstrong SP, Pfleger KD. Ayoub MA, et al. Among authors: see hb. PLoS One. 2013 May 20;8(5):e64672. doi: 10.1371/journal.pone.0064672. Print 2013. PLoS One. 2013. PMID: 23700486 Free PMC article.

8

Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease.

Ayoub MA, Zhang Y, Kelly RS, See HB, Johnstone EK, McCall EA, Williams JH, Kelly DJ, Pfleger KD. Ayoub MA, et al. Among authors: see hb. PLoS One. 2015 Mar 25;10(3):e0119803. doi: 10.1371/journal.pone.0119803. eCollection 2015. PLoS One. 2015. PMID: 25807547 Free PMC article.

9

Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking.

Tiulpakov A, White CW, Abhayawardana RS, See HB, Chan AS, Seeber RM, Heng JI, Dedov I, Pavlos NJ, Pfleger KD. Tiulpakov A, et al. Among authors: see hb. Mol Endocrinol. 2016 Aug;30(8):889-904. doi: 10.1210/me.2016-1002. Epub 2016 Jun 29. Mol Endocrinol. 2016. PMID: 27355191 Free PMC article.

10

Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor.

Ali A, Johnstone EKM, Baby B, See HB, Song A, Rosengren KJ, Pfleger KDG, Ayoub MA, Vijayan R. Ali A, et al. Among authors: see hb. Int J Mol Sci. 2020 Dec 28;22(1):209. doi: 10.3390/ijms22010209. Int J Mol Sci. 2020. PMID: 33379211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters